Skip to main content
BSX
NYSE Life Sciences

Boston Scientific Slashes 2026 Profit Outlook as Watchman Woes Deepen

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$45.36
Mkt Cap
$67.421B
52W Low
$42.2
52W High
$109.5
52W Position info
7.5% above low
Off High info
59% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

BSX is trading near its 52-week low of $42.2 (7.5% above the low).

Summary

Boston Scientific cut its 2026 adjusted EPS guidance to $3.28-$3.32 from $3.34-$3.41, below the $3.36 consensus, citing slower Watchman device uptake and intensifying U.S. electrophysiology competition. CEO Michael Mahoney warned these headwinds will persist into 2027, marking a significant reset from the May slowdown warning. The company also announced a global restructuring with $700M-$800M in charges aimed at $500M in savings. Q2 adjusted EPS of $0.86 beat estimates by $0.03, but the lowered outlook overshadowed the beat. Shares fell nearly 3% in morning trading. The forecast cut follows the May disclosure of Watchman softness and Monday's restructuring approval, signaling deeper operational challenges.

Updates

  1. · Benzinga — Q3 guidance: sales $5.217B-$5.318B vs. $5.358B consensus; adjusted EPS $0.80-$0.82 vs. $0.83 consensus. Shares fell 6.17% to $43.22.

At the time of this announcement, BSX was trading at $45.36 on NYSE in the Life Sciences sector, with a market capitalization of approximately $67.4B. The 52-week trading range was $42.20 to $109.50. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

BSX - Latest Insights

BSX
Nov 02, 2026, 5:54 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $44.16
Real-time Price: $43.03 info
Change: -$1.13 (-3%) info
Market Cap: $62.371B info
BSX
Nov 02, 2026, 5:26 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $44.24
Real-time Price: $43.03 info
Change: -$1.21 (-3%) info
Market Cap: $62.371B info
BSX
Oct 29, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $42.15
Real-time Price: $43.03 info
Change: +$0.8799 (+2%) info
Market Cap: $62.371B info
BSX
Oct 28, 2026, 10:52 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $42.11
Real-time Price: $43.03 info
Change: +$0.925 (+2%) info
Market Cap: $62.371B info
BSX
Oct 28, 2026, 6:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $42.85
Real-time Price: $43.03 info
Change: +$0.180 (+0.42%) info
Market Cap: $62.371B info